Trademark: RESIDUAL CANCER BURDEN
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
RESIDUAL CANCER BURDEN
Click here to search for trademarks similar to RESIDUAL CANCER BURDEN
Proof of use for RESIDUAL CANCER BURDEN
We do not have any records of a proof of use for RESIDUAL CANCER BURDEN at this moment.
Possible trademark infringements of RESIDUAL CANCER BURDEN
Basic Information about RESIDUAL CANCER BURDEN
- Serial Number
- 97205532
- Filing Date
- 06 Jan 2022
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of RESIDUAL CANCER BURDEN on the blockchain with WikiTrademarks.io.
- First use of RESIDUAL CANCER BURDEN anywhere
- RESIDUAL CANCER BURDEN was first used on 01 Oct 2007 for the primary classification of goods and services, international, 010 (Medical Apparatus)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 010
- US Codes
- 026; 039; 044
- First use of RESIDUAL CANCER BURDEN anywhere
- RESIDUAL CANCER BURDEN was first used on 01 Oct 2007 for the primary classification of goods and services, international, 042 (Computer, scientific & legal)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 042
- US Codes
- 100; 101
- First use of RESIDUAL CANCER BURDEN anywhere
- RESIDUAL CANCER BURDEN was first used on 01 Oct 2007 for the primary classification of goods and services, international, 044 (Medical, beauty & agricultural)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 044
- US Codes
- 100; 101
- First use of RESIDUAL CANCER BURDEN anywhere
- RESIDUAL CANCER BURDEN was first used on 01 Oct 2007 for the primary classification of goods and services, international, 045 (Personal)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 045
- US Codes
- 100; 101
Who owns RESIDUAL CANCER BURDEN?
1. Delphi Diagnostics, Inc. Houston TX
Correspondent
- Naira Simmons
- FisherBroyles, LLP
- 32 School Ln
- Scarsdale NY 10583
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io